David M Barry1, Yeon Koo1, Pieter R Norden1, Lyndsay A Wylie1, Ke Xu1, Chonlarat Wichaidit1, D Berfin Azizoglu1, Yi Zheng1, Melanie H Cobb1, George E Davis1, Ondine Cleaver2. 1. From the Department of Molecular Biology and Center for Regenerative Science and Medicine (D.M.B., Y.K., K.X., D.B.A., O.C.) and Department of Pharmacology (C.W., M.H.C.), University of Texas Southwestern Medical Center, Dallas; Department of Medical Pharmacology and Physiology, University of Missouri, Columbia (P.R.N., G.E.D.); Department of Biology, University of North Carolina, Chapel Hill (L.A.W.); and Division of Experimental Hematology and Cancer Biology, Children's Hospital Research Foundation, University of Cincinnati, OH (Y.Z.). 2. From the Department of Molecular Biology and Center for Regenerative Science and Medicine (D.M.B., Y.K., K.X., D.B.A., O.C.) and Department of Pharmacology (C.W., M.H.C.), University of Texas Southwestern Medical Center, Dallas; Department of Medical Pharmacology and Physiology, University of Missouri, Columbia (P.R.N., G.E.D.); Department of Biology, University of North Carolina, Chapel Hill (L.A.W.); and Division of Experimental Hematology and Cancer Biology, Children's Hospital Research Foundation, University of Cincinnati, OH (Y.Z.). ondine.cleaver@utsouthwestern.edu.
Abstract
RATIONALE: Vascular tubulogenesis is essential to cardiovascular development. Within initial vascular cords of endothelial cells, apical membranes are established and become cleared of cell-cell junctions, thereby allowing continuous central lumens to open. Rasip1 (Ras-interacting protein 1) is required for apical junction clearance, as well as for regulation of Rho GTPase (enzyme that hydrolyzes GTP) activity. However, it remains unknown how activities of different Rho GTPases are coordinated by Rasip1 to direct tubulogenesis. OBJECTIVE: The aim of this study is to determine the mechanisms downstream of Rasip1 that drive vascular tubulogenesis. METHODS AND RESULTS: Using conditional mouse mutant models and pharmacological approaches, we dissect GTPase pathways downstream of Rasip1. We show that clearance of endothelial cell apical junctions during vascular tubulogenesis depends on Rasip1, as well as the GTPase Cdc42 (cell division control protein 42 homolog) and the kinase Pak4 (serine/threonine-protein kinase 4). Genetic deletion of Rasip1 or Cdc42, or inhibition of Pak4, all blocks endothelial cell tubulogenesis. By contrast, inactivation of RhoA (Ras homologue gene family member A) signaling leads to vessel overexpansion, implicating actomyosin contractility in control of lumen diameter. Interestingly, blocking activity of NMII (nonmuscle myosin II) either before, or after, lumen morphogenesis results in dramatically different tubulogenesis phenotypes, suggesting time-dependent roles. CONCLUSIONS: Rasip1 controls different pools of GTPases, which in turn regulate different pools of NMII to coordinate junction clearance (remodeling) and actomyosin contractility during vascular tubulogenesis. Rasip1 promotes activity of Cdc42 to activate Pak4, which in turn activates NMII, clearing apical junctions. Once lumens open, Rasip1 suppresses actomyosin contractility via inhibition of RhoA by Arhgap29, allowing controlled expansion of vessel lumens during embryonic growth. These findings elucidate the stepwise processes regulated by Rasip1 through downstream Rho GTPases and NMII.
RATIONALE: Vascular tubulogenesis is essential to cardiovascular development. Within initial vascular cords of endothelial cells, apical membranes are established and become cleared of cell-cell junctions, thereby allowing continuous central lumens to open. Rasip1 (Ras-interacting protein 1) is required for apical junction clearance, as well as for regulation of Rho GTPase (enzyme that hydrolyzes GTP) activity. However, it remains unknown how activities of different Rho GTPases are coordinated by Rasip1 to direct tubulogenesis. OBJECTIVE: The aim of this study is to determine the mechanisms downstream of Rasip1 that drive vascular tubulogenesis. METHODS AND RESULTS: Using conditional mouse mutant models and pharmacological approaches, we dissect GTPase pathways downstream of Rasip1. We show that clearance of endothelial cell apical junctions during vascular tubulogenesis depends on Rasip1, as well as the GTPase Cdc42 (cell division control protein 42 homolog) and the kinase Pak4 (serine/threonine-protein kinase 4). Genetic deletion of Rasip1 or Cdc42, or inhibition of Pak4, all blocks endothelial cell tubulogenesis. By contrast, inactivation of RhoA (Ras homologue gene family member A) signaling leads to vessel overexpansion, implicating actomyosin contractility in control of lumen diameter. Interestingly, blocking activity of NMII (nonmuscle myosin II) either before, or after, lumen morphogenesis results in dramatically different tubulogenesis phenotypes, suggesting time-dependent roles. CONCLUSIONS:Rasip1 controls different pools of GTPases, which in turn regulate different pools of NMII to coordinate junction clearance (remodeling) and actomyosin contractility during vascular tubulogenesis. Rasip1 promotes activity of Cdc42 to activate Pak4, which in turn activates NMII, clearing apical junctions. Once lumens open, Rasip1 suppresses actomyosin contractility via inhibition of RhoA by Arhgap29, allowing controlled expansion of vessel lumens during embryonic growth. These findings elucidate the stepwise processes regulated by Rasip1 through downstream Rho GTPases and NMII.
Keywords:
Ras homologue gene family member A GTP-binding protein; Ras interacting protein 1; actin cytoskeleton; endothelial cells; morphogenesis; myosin type II; tubulogenesis
Authors: Christopher W Wilson; Leon H Parker; Christopher J Hall; Tanya Smyczek; Judy Mak; Ailey Crow; George Posthuma; Ann De Mazière; Meredith Sagolla; Cecile Chalouni; Philip Vitorino; Merone Roose-Girma; Søren Warming; Judith Klumperman; Philip S Crosier; Weilan Ye Journal: Blood Date: 2013-07-25 Impact factor: 22.113
Authors: Stryder M Meadows; Lyndsay A Ratliff; Manvendra K Singh; Jonathan A Epstein; Ondine Cleaver Journal: Dev Dyn Date: 2013-03-29 Impact factor: 3.780
Authors: Xiaolei Liu; Xiaowu Gu; Wanshu Ma; Michael Oxendine; Hyea Jin Gil; George E Davis; Ondine Cleaver; Guillermo Oliver Journal: Development Date: 2018-08-20 Impact factor: 6.868
Authors: Ankita B Jaykumar; Sakina Plumber; David M Barry; Derk Binns; Chonlarat Wichaidit; Magdalena Grzemska; Svetlana Earnest; Elizabeth J Goldsmith; Ondine Cleaver; Melanie H Cobb Journal: Proc Natl Acad Sci U S A Date: 2022-07-22 Impact factor: 12.779
Authors: Zheying Sun; Scott S Kemp; Prisca K Lin; Kalia N Aguera; George E Davis Journal: Arterioscler Thromb Vasc Biol Date: 2021-12-09 Impact factor: 8.311
Authors: Laura M Pillay; Joseph J Yano; Andrew E Davis; Matthew G Butler; Megan O Ezeude; Jong S Park; Keith A Barnes; Vanessa L Reyes; Daniel Castranova; Aniket V Gore; Matthew R Swift; James R Iben; Madeleine I Kenton; Amber N Stratman; Brant M Weinstein Journal: Angiogenesis Date: 2022-03-23 Impact factor: 10.658
Authors: Martin Kragl; Rajib Schubert; Haiko Karsjens; Silke Otter; Barbara Bartosinska; Kay Jeruschke; Jürgen Weiss; Chunguang Chen; David Alsteens; Oliver Kuss; Stephan Speier; Daniel Eberhard; Daniel J Müller; Eckhard Lammert Journal: Nat Commun Date: 2016-12-20 Impact factor: 14.919